UK markets closed

STRATEC Biomedical AG (SBS.DE)

XETRA - XETRA Delayed price. Currency in EUR
Add to watchlist
42.50-0.35 (-0.82%)
At close: 05:35PM CEST
Currency in EUR

Valuation measures4

Market cap (intra-day) 516.63M
Enterprise value 623.78M
Trailing P/E 40.05
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.99
Price/book (mrq)2.23
Enterprise value/revenue 2.38
Enterprise value/EBITDA 15.63

Trading information

Stock price history

Beta (5Y monthly) 0.13
52-week change 3-32.86%
S&P500 52-week change 322.38%
52-week high 369.00
52-week low 336.00
50-day moving average 341.50
200-day moving average 343.56

Share statistics

Avg vol (3-month) 39k
Avg vol (10-day) 312.86k
Shares outstanding 512.16M
Implied shares outstanding 612.16M
Float 87.25M
% held by insiders 140.55%
% held by institutions 140.78%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.55
Forward annual dividend yield 41.28%
Trailing annual dividend rate 30.55
Trailing annual dividend yield 31.28%
5-year average dividend yield 41.21
Payout ratio 490.65%
Dividend date 3N/A
Ex-dividend date 420 May 2024
Last split factor 22.994:1
Last split date 331 Jul 2006

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 4.81%
Operating margin (ttm)4.23%

Management effectiveness

Return on assets (ttm)3.65%
Return on equity (ttm)5.29%

Income statement

Revenue (ttm)252.3M
Revenue per share (ttm)20.76
Quarterly revenue growth (yoy)-15.90%
Gross profit (ttm)N/A
EBITDA 36.91M
Net income avi to common (ttm)12.14M
Diluted EPS (ttm)1.06
Quarterly earnings growth (yoy)-67.30%

Balance sheet

Total cash (mrq)19.13M
Total cash per share (mrq)1.57
Total debt (mrq)142.07M
Total debt/equity (mrq)61.98%
Current ratio (mrq)2.32
Book value per share (mrq)18.86

Cash flow statement

Operating cash flow (ttm)15.89M
Levered free cash flow (ttm)-23.93M